CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

Daiichi Sankyo ENHERTU® is Now Available in the U.S. for the HER2 Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2-Based...

admin - 0
Latest Pharma-News

FDA approves less invasive surgical approach for Abbott’s heart pump in order to help patients avoid Open Heart Surgery

admin - 0
Latest Pharma-News

Dietary supplements containing zinc and folic acid marketed as a treatment for male infertility does not improve pregnancy rates, sperm counts or sperm function

admin - 0
Latest Pharma-News

BMS Completes Divestment of its oral solid, biologics, and sterile product Manufacturing and packaging Facility in Anagni, Italy

admin - 0
Latest Pharma-News

FDA Ok’s Teleflex for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

admin - 0
Latest Pharma-News

Valneva Announces End of Phase 2 Meeting with the FDA for its Chikungunya Vaccine Candidate

admin - 0
Latest Pharma-News

BAVENCIO (avelumab) extensively Improved Overall Survival in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

admin - 0
Latest Pharma-News

FDA approved AstraZeneca’s Farxiga(dapagliflozin) for Priority Review for the patients with heart failure with reduced ejection fraction

admin - 0
Latest Pharma-News

AVITA medical receives U.S. FDA investigational device exemption approval of clinical feasibility study in order to evaluate Recell system for Vitiligo

admin - 0
Latest Pharma-News

U.S. Food and Drug Administration (FDA) approved sNDA to Revise Flexion Therapeutic’s ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis (OA)...

admin - 0
Latest Pharma-News

U.S. Food and Drug Administration (FDA) approved Allergan’s UBRELVY(ubrogepant) for the acute treatment of migraine with or without aura in adults.

admin - 0
Latest Pharma-News

U.S. FDA approves EISAI’S DAYVIGO™ (LEMBOREXANT) for treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults

admin - 0
1...134135136...145Page 135 of 145
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved